Post-approval studies (Phase 4)Study completedNCT02523287
What this trial is testing
Placebo Controlled Study to Generate Data Characterising Clinical Events, Physiological Responses and Immune Responses
Who this might be right for
Safety Markers of Adjuvanted Influenza Vaccine
University Hospital, Ghent 240